iBio (IBIO) Raw Materials (2021 - 2022)
iBio (IBIO) posted Raw Materials of $3.9 million for fiscal Q4 2022 (quarter ended Jun 30, 2022), up 18.7% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Raw Materials (2021 - 2022) Analysis & Trends
Since fiscal Q1 2022, iBio has reported Raw Materials for 4 quarters.
- According to Business Quant data, Raw Materials for the three prior fiscal quarters was $3.28 million (Q3 2022), $1.96 million (Q2 2022) and $487,000 (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 1.96 Mn |
| Sep 30, 2021 | 487,000.00 |
API Access
iBio Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();